CD44 and hepatocellular carcinoma: We previously found a cross-talk between the Transforming Growth Factor (TGF)-β pathway and the acquisition of a mesenchymal-like phenotype with up-regulation of CD44 expression in HCC cell lines, CD44 playing an active role in protecting these cells from sorafenib-induced apoptosis [16, 29].